Skip to main content
. Author manuscript; available in PMC: 2020 Nov 24.
Published in final edited form as: Curr Oncol Rep. 2020 Jun 24;22(7):74. doi: 10.1007/s11912-020-00913-y

Figure 1.

Figure 1.

Fecal microbiota transplant to enhance immunotherapy in cancer patients: overview of the potential role of fecal microbiota transplant (FMT) as a therapeutic strategy to modulate the gut microbiome. Through FMT, donor microbiome is transferred to a recipient in the form of a stool suspension given either endoscopically or via pills. Key considerations in the design of FMT interventions include patient selection, donor profile, timing, FMT modality, and post-FMT follow-ups.